-
Continue reading →: Chemtura’s Patent restored
The Bombay High Court’s division bench has set aside the order of the IPAB revoking Chemtura’s patent IN213608 and has directed the Controller of Patents to restore the patent on the e-register ( Order dated 19-06-2017 ). IPAB had earlier revoked Chemtura’s Patent for non compliance of section 8 and lack…
-
Continue reading →: Chemtura’s Patent restored
The Bombay High Court’s division bench has set aside the order of the IPAB revoking Chemtura’s patent IN213608 and has directed the Controller of Patents to restore the patent on the e-register. IPAB had earlier revoked Chemtura’s Patent for non compliance of section 8 and lack of inventive step. Chemtura…
-
Continue reading →: SC allows Cipla to withdraw its petition
The Supreme Court (SC) of India has allowed domestic drug manufacturer Cipla, which to withdraw its petition in respect of the patent dispute with Roche over the drug erlotinib hydrochloride. The petition was filed by Cipla challenging the High Court’s order holding that it had infringed Roche’s patent. The two companies, Roche…
-
Continue reading →: Reasons beyond control necessary for condoning delay in submitting response to Examination report
The Indian Patent office while considering a petition filed by Cisco Technologies under rule 137 for condonation of delay in filing response to examination beyond the statutory period, refused to allow such delay as according to the controller all possible reasons as mentioned by the applicant’s agent such as lack…
-
Continue reading →: Rules for appointment of IPAB Chairman, Vice-Chairman, Technical Member
In exercise of the powers conferred by section 184 of the Finance Act, 2017 (7of 2017), the Central Government has notified the Tribunal, Appellate Tribunal and other Authorities (Qualifications, Experience and other Conditions of Service of Members) Rules, 2017 on 1st June 2017. These rules apply to 19 Appellate Tribunal…
-
Continue reading →: Non-compliant defendants face permanent injunction
DSM Sinochem Pharmaceuticals has been granted permanent injunction against Sinopharma Weiqida pharmaceuticals as the defendants failed to timely submit the defense (written statement) and pay the costs imposed by the Court. The Plaintiffs DSM Sinochem Pharmaceuticals sued Sinopharma Weiqida pharmaceuticals for permanent injunction to restrain them from using , manufacturing ,…
-
Continue reading →: Access Benefit Sharing
Justice U.C. Dhyani of Uttarakhand High court passed a ruling deciding several writ petitions filed by various paper mill companies against notices issued against them by the Uttarakhand State Biodiversity Board (SBB). The impugned notices were sent by SBB as it considered that the petitioners failed to provide prior intimation to…
-
Continue reading →: CCI orders Investigation against Roche
The Competition Commission of India (CCI), based on a prima facie determination on contravention of Section 4(2)(c) of the Competition Act, ordered investigation against Roche with respect to the cancer drug, Trastuzumab. The complaint was filed by Biocon and Mylan Pharmaceuticals. Facts of the case: – Genentech developed a monoclonal…
-
Continue reading →: Annual Report – IPO
The annual Report 2015-16 of the Office of Controller General of Patents, Designs & Trade Marks has been published. Some noticeable points are as follows:- 10% increase in patent filing compared to 2014-15. Total filing in 2015-16 being 40,946. 8% filings have increased by Indian applicants, and approximately 10% by…
Greetings
Welcome to Patents Rewind, Anand and Anand’s Patents and Designs blog that offers you an Indian perspective on issues surrounding patent and design eligibility and enforcement through latest case law and developments in the Indian patents and designs landscape.
Let’s connect
Join us!
Stay updated with our posts.
